Ondrej Blaha

5PUBLICATIONS
56CO-AUTHORS
Regenerative medicine (incl. stem cells)Stochastic analysis and modellingMajor global burdens of diseaseGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Feb 11, 2025
Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios.

Xinyu Zhang, Erich J Greene, Ondrej Blaha

|Dec 02, 2024
Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database.

Abdulrahman Alhajahjeh, Lara K Rotter, Jessica M Stempel

|Apr 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling.

Wei Wei, Ondrej Blaha, Denise Esserman

|Mar 11, 2023
ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer.

Ziqi Li, Erika Belitzky, Ondrej Blaha

Pageof 1

Frequent Collaborators

2 joint publications

Wei Wei

2 joint publications

Amer M Zeidan

2 joint publications

Jan Philipp Bewersdorf

2 joint publications

Jessica M Stempel